130
Participants
Start Date
April 1, 2019
Primary Completion Date
September 30, 2020
Study Completion Date
March 31, 2021
Collection of stool, blood (PBMC) and biopsy (FFPE)
Patients receiving routine treatment (immunotherapy using anti-PD1 / anti-PDL1 and / or anti CTLA4 antibodies), financed by the Polish National Health Fund (NFZ).
RECRUITING
University Clinical Centre in Gdansk, Gdansk
RECRUITING
The John Paul II Hospital in Krakow, Krakow
NOT_YET_RECRUITING
The Maria Sklodowska-Curie National Research Institute of Oncology Krakow Branch, Krakow
WITHDRAWN
Poznań University Hospital of Lord's Transfiguration, Poznan
RECRUITING
Provincial Hospital St. Father Pio in Przemyśl, Przemyśl
RECRUITING
"Mountains Center of Pulmonology and Chemotherapy Izer-Med", Szklarska Poręba
RECRUITING
Specialist Oncological Hospital, Tomaszów Mazowiecki
RECRUITING
The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Warsaw
RECRUITING
Masovian Oncology Hospital in Wieliszew, Wieliszew
WITHDRAWN
Lower Silesian Oncology Center & Łukasiewicz Research Network - PORT Polish Center For Technology Development, Wroclaw
Lead Sponsor
National Center for Research and Development, Poland
OTHER
Ardigen
INDUSTRY